Literature DB >> 219877

Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.

K James, I Milne, J Merriman, W H McBride.   

Abstract

The ability of s.c. injected tumour cells to specifically inhibit the growth of similar cells injected i.v. 2 days later has been confirmed. The capacity of tumour cells to elicit this effect varies form tumour to tumour. Furthermore, it is more readily achieved with cultured than with freshly excised tumour cells. The superior effect elicited by cultured tumour cells was not overcome by treating them with trypsin or pronase. The protection achieved was impaired in T-cell-depleted mice and mice which had been irradiated (400 rad) prior to pretreatment. In contrast, it was not affected by administration of silica, sodium aurothiomolate or cortisone acetate. The results imply that T-cell-dependent responses are involved in the protection conferred by pre-injecting tumour cells shortly before i.v. challenge.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219877      PMCID: PMC2009838          DOI: 10.1038/bjc.1979.22

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.

Authors:  J M Yuhas; N H Pazmiño; E Wagner
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

2.  Characterization of a fetal calf serum-derived molecule reactive with human natural antibodies: its occurrence in tissue culture-grown type C RNA viruses.

Authors:  H W Snyder; M Fox
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells.

Authors:  B Schechter; M Feldman
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

4.  Rapid adsorption of a foetal calf serum component by mammalian cells in culture. A potential source of artifacts in studies of antisera to cell-specific antigens.

Authors:  R S Kerbel; D Blakeslee
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

5.  Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

6.  Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum.

Authors:  A Ghaffar; R T Cullen; N Dunbar; M F Woodruff
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

7.  Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.

Authors:  G R Pasternack; R Snyderman; M C Pike; R J Johnson; H S Shin
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

8.  Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum.

Authors:  P D Jones; J E Castro
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

9.  Antitumour responses induced by short-term pretreatment with tumour cells.

Authors:  K James; R T Cullen; I Milne; M Norval
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

10.  Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.

Authors:  M F Woodruff; V L Whitehead; G Speedy
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

View more
  1 in total

1.  Association of host immunoglobulins with solid tumours in vivo.

Authors:  K James; Y H Bessos; J Merriman
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.